| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 187 | 488 | 1,976 | | Cost of Revenue | 22 | 54 | 119 | | | Gross Profit | 166 | 433 | 1,857 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 423 | 773 | 1,203 | | Non Recurring | 281 |
-
|
-
| | Others | (670) | 17 | 3,413 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 131 | (356) | (2,759) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 110 | | Earnings Before Interest And Taxes | 131 | (356) | (2,649) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 131 | (356) | (2,649) | | Income Tax Expense |
-
|
-
| 15 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 131 | (356) | (2,664) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 131 | (356) | (2,664) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $131 | ($356) | ($2,664) |
|
0.03% Nasdaq 0.00%
Income Statement
